Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ABBV - AbbVie Inc.


Close
178.36
0.245   0.137%

Share volume: 119,600
Last Updated: Wed 08 Jan 2025 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.55%

PREVIOUS CLOSE
CHG
CHG%

$178.12
0.25
0.14%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2023-05-05 2023-08-07 2023-11-06 2024-02-20 2024-05-03
Assets
Total Assets 134.544 B 135.367 B 136.221 B 134.711 B 148.874 B
Current Assets 26.488 B 28.852 B 33.224 B 33.002 B 38.871 B
Inventories 3.833 B 4.055 B 3.981 B 4.099 B 4.245 B
Other Current Assets 4.460 B 4.540 B 4.541 B 4.932 B 4.608 B
Short Term Investments 4.460 B 4.540 B 4.541 B 4.932 B 4.608 B
Total Receivables 11.473 B 11.491 B 11.412 B 11.155 B 11.949 B
Current Cash 6.722 B 8.766 B 13.290 B 12.816 B 18.069 B
Total Non-current Assets 108.056 B 106.515 B 102.997 B 101.709 B 110.003 B
Property Plant Equipment 4.931 B 4.943 B 4.934 B 4.989 B 4.980 B
Other Assets 5.800 B 6.198 B 7.094 B 8.513 B 9.067 B
Intangible Assets 64.848 B 62.862 B 58.603 B 55.610 B 62.225 B
Goodwill 32.220 B 32.224 B 32.091 B 32.293 B 33.426 B
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 134.544 B 135.367 B 136.221 B 134.711 B 148.874 B
Total liabilities 121.270 B 122.501 B 124.127 B 124.351 B 140.867 B
Total current liabilities 27.590 B 32.239 B 34.773 B 37.841 B 41.522 B
Accounts Payable 0.000 0.000 0.000 3.688 B 0.000
Other liabilities 32.249 B 32.294 B 31.644 B 32.327 B 32.778 B
Current long term debt 2.801 B 5.203 B 5.115 B 7.191 B 10.196 B
Long term debt 59.292 B 55.812 B 55.631 B 52.194 B 63.805 B
Other liabilities 32.249 B 32.294 B 31.644 B 32.327 B 32.778 B
Minority interest 29.000 M 32.000 M 35.000 M 37.000 M 40.000 M
Total Shareholder equity 13.274 B 12.866 B 12.094 B 10.360 B 8.007 B
Common stock 1.770 B 1.767 B 1.767 B 1.768 B 1.769 B
Retained earnings 2.393 B 1.789 B 933.000 M -1.000 B -2.384 B